TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
3 Stocks at 52-Week Lows I’m Buying Right Now
Cannabis Stocks
What’s Happening With Cannabis Stocks in May 2023?
Cannabis Stocks
Are Cannabis Stocks a Good Buy in May 2023?
Tech Stocks
These Undervalued TSX Stocks Are a Bargain in May 2023
Metals and Mining Stocks
2 Canadian Stocks That Are Simply Too Cheap to Avoid
Cannabis Stocks
Is Canopy Growth Stock a Buy or a Sell in April 2023?
Cannabis Stocks
Canopy Growth Stock Is Setting Up for Long-Term Growth, But Will Investors Wait?
Cannabis Stocks
Are Cannabis Stocks a Good Buy in April 2023?